Rationale Serotonin (5-HT) was implicated in both clinical and experimental studies in flexible, goal-directed behavior. However, the way in which 5-HT manipulations affect brain activation patterns underlying different subprocesses of cognitive flexibility remains largely unknown. Objectives The aim of this study was to investigate the effect of a transient lowering of 5-HT on brain activation during performance monitoring and response inhibition. Materials and methods We used acute tryptophan depletion (ATD), a well-known method to reduce central 5-HT, to investigate the effect of a transient lowering of 5-HT on the blood-oxygen-level dependent (BOLD) response in an event-related functional MRI study. Thirteen healthy male volunteers performed a modified Go/NoGo task in a counterbalanced, placebo-controlled, within-subject design. Results ATD significantly lowered plasma tryptophan but did not affect mood and cognitive performance. ATD decreased the BOLD response in the dorsomedial prefrontal cortex (BA 8) during performance monitoring. ATD did not affect the BOLD response during response inhibition. Conclusions This study provides more evidence for the suggested role of 5-HT in performance monitoring. Because ATD studies have revealed inconsistent effects of ATD on performance and on brain activation, it was suggested that gender and personality traits are important variables to take into account for future research.
Introduction
Previous animal and human research showed that serotonin (5-HT) is implicated in cognitive flexibility tasks (for review, see Robbins 2005) . Cognitive flexibility is the ability to quickly adapt performance to task-related changes. It was shown that acute tryptophan depletion (ATD), a method to temporarily reduce brain 5-HT levels, impaired performance during reversal learning (Park et al. 1994; Rogers et al. 1999 ) and decision making (Rogers et al. 1999 in healthy volunteers. In contrast, other studies did not find an effect of reduced 5-HT on cognitive flexibility (Anderson et al. 2003; Talbot et al. 2005 ). Several cognitive processes are important for cognitive flexibility, for example performance monitoring and response inhibition. It remains unclear how these processes are affected by a transient lowering of 5-HT. The present study investigated the effect of low 5-HT on performance and brain activation during performance monitoring and response inhibition.
Previous studies showed that low 5-HT impaired performance monitoring and response inhibition. For example, patients suffering from unipolar depression, a disorder associated with disturbed 5-HT functioning (for review, see Risch and Nemeroff 1992) , showed an impaired response to negative feedback. Two previous studies (Beats et al. 1996; Elliott et al. 1997) reported that depressed patients fail to improve performance after perceived failure, which suggests cognitive inflexibility. Murphy et al. (2003) showed impaired ability to maintain a response set in the face of misleading negative feedback in depressed patients, which indicates an increased tendency to change response strategy. Fallgatter et al. (2004) investigated the modulation of the brain electrical response to error processing as a function of allelic variation of 5-HT transporter function. They showed significantly higher amplitude of the errorrelated negativity, indicating an enhanced responsiveness of the anterior cingulate cortex (ACC) during error processing, when participants carried a short allele of the 5-HT transporter. Animal studies showed that the administration of the neurotoxin 5,7-dihydroxytryptamine, depleting brain 5-HT, resulted in poorer response inhibition on a Go/NoGo task (Harrison et al. 1999) and increased impulsivity in a five-choice, serial reaction time task (Harrison et al. 1997; Winstanley et al. 2004 ) in rats. Furthermore, depressed patients showed disturbed response inhibition on a Go/ NoGo task (Kaiser et al. 2003) . In contrast to the suggested importance of 5-HT for response inhibition, no effects of ATD were found on response inhibition performance in healthy volunteers Cools et al. 2005a; Crean et al. 2002; Le Marquand et al. 1998 Rubia et al. 2005) . Only one study that we are aware of showed an increase in impulsive response style after ATD (Walderhaug et al. 2002) .
Three previous functional MRI (fMRI) studies investigated the effect of ATD on brain activation while healthy volunteers performed a cognitive task. Horacek et al. (2005) showed that ATD increased activation in the bilateral medial, inferior, and superior prefrontal cortex (PFC) and in the ACC during the interference condition of a Stroop task. Rubia et al. (2005) investigated the effect of ATD on brain activation during response inhibition using a standard Go/NoGo task. ATD increased the bloodoxygen-level dependent (BOLD) response in the superior and medial temporal cortices, but decreased the BOLD response in the right inferior PFC during response inhibition. Finally, Evers et al. (2005) showed that ATD increased the BOLD response in the dorsomedial PFC (dmPFC) during probabilistic reversal learning. In addition, two positron-emission tomography studies have examined the effect of ATD on the activation of a resting brain in depressed patients (Bremner et al. 1997; Smith et al. 1999; Morris et al. 1999) . A diverse range of areas was affected by ATD including the orbitofrontal cortex, the ACC, the caudate, raphe and habenula nucleus, the thalamus, and the dorsolateral PFC.
The aim of the current study was to investigate the effect of a transient lowering of 5-HT, by means of ATD, on brain activation patterns underlying performance monitoring and response inhibition. ATD is a well-established, noninvasive method that adequately reduces the release and synthesis of brain 5-HT in humans (Biggio et al. 1974; Fadda 2000; Williams et al. 1999; Nishizawa et al. 1997) . In the present study, healthy male volunteers performed a modified Go/NoGo task in which performance feedback was given after each response, in an event-related fMRI design. In accordance with above-mentioned studies that showed that ATD did not affect response inhibition in healthy volunteers, we hypothesized that performance would not be affected by ATD. Furthermore, we hypothesized that ATD affects the BOLD response in dorsomedial frontal regions (based on Evers et al. 2005; Fallgatter et al. 2004 ) during performance monitoring and in the right inferior frontal cortex (based on Rubia et al. 2005 ) during response inhibition.
Materials and methods

Participants
Seventeen healthy, right-handed male volunteers were included in this study, which was approved by the Medical Ethics Committee of the Maastricht University Hospital. Data of four volunteers could not be used for analysis due to technical problems. The remaining participants (n=13) were, on average, 23 years old (SD=1.8) and were mostly pregraduate students. Participants were recruited by local advertisements and were not suffering from significant past or present physical or psychiatric illnesses, which was checked by a medical health questionnaire. They received no medication at the moment of inclusion and were screened for MRI contraindications. This study was carried out in accordance with the declaration of Helsinki and all volunteers gave written informed consent before their inclusion in the study. The participants were paid 75 euros.
Experimental design
Participants were scanned at the Academic Hospital Maastricht on two separate test days, that is, an experimental and a placebo test session counterbalanced according to a double-blind crossover design. Participants arrived in the afternoon, after they have fasted overnight and eaten a lowprotein breakfast at home. They were given a tryptophandepleted (TRP-) or a balanced (BAL) amino acid (AA) mixture, followed by a 5-h break to ensure stable and low plasma TRP levels (Riedel et al. 1999) . In this break, only low protein food was eaten. In the evening (between 5 and 8.30 p.m.) the participants were scanned while performing two blocks of the Go/NoGo task, each lasting about 5.5 min. The participants also performed a memory task, but the results of this part of the experiment will be presented elsewhere (van der Veen et al. 2006) . The order of testing was as follows: the first Go/NoGo block (5.5 min), the encoding block of the memory task (7.5 min), the second Go/NoGo block (5.5 min), the structural scan (10 min), and the recognition block of the memory task (11 min). Participants were trained in a dummy scanner on a separate day before the first test sessions to make sure that they were comfortable in the scanner and they could perform the task well.
The Go/NoGo task
The present study used a modified version of the Go/NoGo task described by Garavan et al. (1999) . The task was programmed in E-Prime V1.0 (Psychology Software Tools 2002). A stream of letters (yellow on a black background) was presented, showing one letter every 500 ms with a 0-ms interstimulus interval. The participants' task was to respond to an X preceded by a Y or a Y preceded by an X (Go trials) by pressing a button on a response box with their right index finger. Participants had to refrain from responding when an X was preceded by an X or a Y by a Y (NoGo or inhibition trials). Feedback, which started 500 ms after the presentation of a letter (fixed delay) and was presented for 500 ms, was added to the original task design to motivate the participants. Correct Go and NoGo trials were followed by a green square (positive feedback); incorrect responses were followed by a red square (negative feedback). Negative feedback was given after a response to an inhibition trial, a response to a letter other than an X or a Y, no response to a Go trial, or a response was given after a time limit of 500 ms. This time limit was added to assure fast response. The response had to be made when the stimulus was still on the screen. Feedback was given after the stimulus presentation. A NoGo trial was presented every 25 s on average and a Go trial every 4 s on average. In each test session, 1,000 stimuli were presented, of which 25 were NoGo and 150 were Go trials, divided into two blocks each lasting about 5 min. Four different versions were used in a randomized order. Participants were trained before the actual testing. In the first training task, no NoGo trials (400 stimuli, of which 120 were Go trials), and in the second training task, seven NoGo trials (350 stimuli, of which 55 were Go trials and 7 were NoGo trials) were presented in addition to the Go trials. The experimental task contained three events of interest: correctly executed Go trials followed by positive feedback (Gos) correctly inhibited NoGo trials followed by positive feedback (NoGos) and errors on Go or NoGo trials followed by negative feedback (Errors).
Performance data
The following measures were used: the number of correct Gos, the number of correct NoGos, the mean reaction time (RT) on Go trials after a correct response (a measure for general responding speed), after an incorrect Go, and after an incorrect NoGo trial, (measures for the behavioral adaptation after a response error). The effect of ATD on the number of correct Gos, the number of correct NoGos, and the RT measures was analyzed (SPSS version 11.5 for Windows) using repeated measures ANOVA with Treatment (BAL or TRP-) as a within subject variable and Order (TRP-or BAL mixture first) as a between subject variable. The differences between the RT measures within the BAL and TRP-conditions were analyzed using paired-samples t tests.
Amino acid mixtures
The TRP-deficient (TRP-) amino acid (AA) mixture contained 75 g of AAs with the amounts of each specific AA according to the following proportions:
.7 g L-valine, 3.7 g L-arginine, 2.0 g L-cysteine, and 2.3 g L-methionine. The nutritionally balanced (BAL) mixture contained the same amount of these AAs, plus 3.0 g TRP. The mixtures were prepared with 200 ml tap water.
Biochemical measures
Blood samples (10 ml) were taken immediately before ingestion of the AA mixture and just before the scanning session, about 4 1/2 h after administration, to determine the plasma TRP level and the TRP/ΣLNAA ratio. The TRP/ ΣLNAA ratio was calculated as follows: (TRP) / (tyrosine + leucine + phenylalanine + isoleucine + valine). The blood samples were immediately centrifuged at 4°C (10 min, 4,500 rpm). One hundred microliters aliquot of plasma was mixed with 8 mg sulfa salicylic acid and frozen at −80°C until determination of the AAs by high-performance liquid chromatography (van Eijk et al. 1993) . Total plasma TRP level and the TRP/ΣLNAA ratio were analyzed using repeated measures ANOVA with Time (t0 and t5) and Treatment (BAL or TRP-) as within-subject variables and Order (TRP-or BAL mixture first) as between subject variable. Paired-sample t tests were used to compare baseline measurements.
Questionnaires
Mood
A visual analog version of the Profile of Mood States (POMS) was used to assess mood (McNair et al. 1988 ). This questionnaire consists of 32 bipolar sets of adjectives, which measure five mood dimensions: anger, depression, fatigue, tension, and vigor. The items were scored on a 10-point scale. When the participants felt as they normally would, they were asked to mark the middle of the line (score 5).
Adverse effect
Adverse effects, 31 items, were registered and scored on a 4-point scale from "no complaint at all" (0) to "severe complaint" (4). A total score was calculated by adding the scores on the individual items.
The effect of ATD on mood and adverse effects was analyzed using repeated measures ANOVA with Time (t0 and t5) and Treatment (BAL or TRP-) as within-subject variables and Order (TRP-or BAL mixture first) as between subject variable.
Image acquisition
Participants were scanned in a 1.5 T Philips scanner at the Academic Hospital Maastricht. T2*-weighted gradient echo planer images (TE=27 ms) were acquired with BOLD contrast. A whole brain acquisition consisted of 24 slices (slice thickness 5 mm; TR 1.75 s; voxel size before normalization was 3.5×3.5×5 mm and after normalization 2×2×2 mm; no slice gap; matrix size 64×64×24; oblique transversal orientation; flip angle 90°), and 190 volumes were acquired for each Go/NoGo block. The stimulus presentation and the scanning were synchronized at the beginning of each run. High-resolution T1-weighted images for anatomical localization were made of each participant (voxel size 1×1×1 mm).
Image analysis SPM2 (Statistical Parametric Mapping; Wellcome Department of Cognitive Neurology, London, UK) was used for data processing. Preprocessing procedures included slice acquisition time correction and within-subject realignment. Images from session 2 were then coregistered to the mean image from session 1 and thereafter spatially normalized to the standard Montreal Neurological Institute (MNI) structural template (SPM2). Finally, the images were spatially smoothed using a Gaussian (8 mm full-width at half maximum) kernel and high pass filtered.
A canonical hemodynamic response was used as a covariate in a general linear model, and a parametric estimate was generated for each voxel for Gos, NoGos, and Errors. Individual contrast images were taken to a second level analysis (one sample t test), in which t values were calculated for each voxel treating intersubject variability as a random effect. The hemodynamic response function was modeled to the onset of the response.
The following contrasts were calculated for the BAL and the TRP-condition together to assess task effects (whole brain analysis; P cluster-corrected <0.05):
1. Performance monitoring Errors minus Correct (NoGos+Gos) (contrast 1), (contrast weights-2 1 1) 2. Response inhibition NoGos minus Gos (contrast 2)
The following contrasts were calculated to assess the effect of ATD:
3. Effect of ATD on performance monitoring Contrast 1 in the TRP-condition compared with contrast 1 in the BAL condition (contrast 3) 4. Effect of ATD on response inhibition Contrast 2 in the TRP-condition compared with contrast 2 in the BAL condition (contrast 4) 5. As a control condition, effect of ATD on overall activation All event types (Gos, NoGos, and Errors) in the TRP-condition compared with all event types in the BAL condition (contrast 5)
The effect of ATD was analyzed using whole brain analysis (P cluster-corrected <0.05 and extent threshold of >20 voxels). In a previous study, we showed that ATD increased the BOLD response in the dmPFC region after the last reversal error in a probabilistic reversal learning task (Evers et al. 2005) . This region was used as a region of interest (ROI) (SPM, small volume correction; 10-mm sphere around the center coordinated MNI: x=9, y=39, z=48) for the effect of ATD on brain activation during performance monitoring. The Talaraich Daemon was used to label the coordinates of the anatomical regions (http://ric.uthscsa.edu/TDapplet/).
Results
Performance and fMRI data were complete for 13 participants; eight participants started in the BAL condition and five started in the TRP-condition. Participants were scanned 5 h on average after ingesting the AA mixture.
Imaging
No main task effect was found for performance monitoring (contrast 1; BAL and TRP-data together). However, in the BAL condition performance monitoring was associated with a significantly increased BOLD response in the ACC (MNI, x=6, y=26, z=40; T=5.62; P cluster-corrected =0.037; 156 voxels; BA 32). Response inhibition (contrast 2; BAL and TRP-data together) was associated with a significantly increased BOLD response in a right inferior parietal/ supramarginal cluster (BA 40), a right middle/superior frontal and precentral cluster (BA 10/44/46), a right medial/ superior frontal cluster (BA 6/8), a left superior/inferior parietal and precuneus cluster (BA 7/40), a left inferior/ middle frontal cluster (BA 8/9/47), and a right middle temporal cluster (BA 21) (see Table 1 ).
ATD decreased the BOLD response in the dmPFC cortex (ROI analysis; MNI, x=4, y=44, z=40; T=4.98; P cluster-corrected =0.037; seven voxels; BA 8) during performance monitoring (contrast 3). No effect of ATD was found on brain activation associated with response inhibition (contrast 4). Percent signal change for both the BAL and the TRP-condition in the dmPFC activation cluster is shown in Fig. 1 . Because no effect of ATD on overall activation was found (contrast 5), the effect of ATD in the dmPFC was not confounded by overall effects of ATD. Talbot and Cooper (2006) showed that individual changes in depressed mood after ATD without an overall mood effect affected the BOLD response in the subgenual ACC and associated regions. Therefore, we conducted a post hoc analysis to examine whether the effect of ATD on the BOLD response in the dmPFC is confounded by mood changes. Post hoc ANCOVA analysis showed that the effect of ATD on the response in the dmPFC was not confounded by mood. After correction for the delta depression score [score on the depression subscale of the POMS at TRP-(t5-t0) minus BAL (t5-t0)] ATD decreased the BOLD response in the dmPFC (ROI analysis; MNI, x=4, y=44, z=40; T=4.84; P cluster-corrected =0.048; four voxels; BA 8). In addition, the effect of ATD during performance monitoring was not confounded by the fact that eight participants started in the BAL and five participants in the TRP-condition. Repeated measures analysis with Treatment as within subject factor and Order as between subject factor showed that the percent signal change extracted from the dmPFC (two times Error minus Go and minus NoGo percentage signal change) was not affected by Order (Treatment × Order interaction: F(1,11)=3.6; p=0.08). 
Biochemical results
Twelve samples from the BAL condition and 13 samples from the TRP-condition were available for analysis. No difference in total plasma TRP (mean/SEM, BAL 47.6/1.5; TRP-47.4/1.3) and the TRP/ΣLNAA ratio (BAL 0.10/0.01; TRP 0.10/0.00) at baseline (t0) was found between the BAL and the TRP-condition. In the TRP-condition, total plasma TRP (19.4/2.5) and the TRP/ΣLNAA ratio (0.02/0.00) were significantly lowered [Treatment × Time interaction for total plasma TRP, F(1,10)=44.7, p=0.000; Treatment × Time interaction for the ratio, F(1,10)=96.9, p=0.000] 5 h after the AA mixture. Total plasma TRP dropped by 59% and the TRP/ΣLNAA ratio by 77% after ingesting the TRPmixture. In the BAL condition levels of total plasma TRP (108.5/12.2) were significantly increased (t11=−4.9; p<0.01), but the TRP/ΣLNAA ratio (0.11/0.01) was not changed (T11=−1.15; p>0.05) 5 h after the AA mixture. Total plasma TRP increased by 128% and the TRP/ ΣLNAA ratio increased by 15% after the BAL mixture.
Performance
Performance data (n=13) is shown in Table 2 . No effect of ATD was found on the number of correct Gos and correct NoGos. Participants successfully completed, on average, 18.6 correct NoGos (SE=1.2) in the TRP-condition and 17.1 correct NoGos (SE=1.5) in the BAL condition. Participants made on average 17 Errors (SE=3.5) in the TRP-condition and 21 Errors (SE=4.3) in the BAL condition. In the BAL and in the TRP-condition, participants reacted faster on a correct Go trial after a correct response than on a correct Go trial after an incorrect Go trial (BAL, T=−4.77, p=0.000; TRP-, T=−3.5, p=0.001) and after an incorrect NoGo trial (BAL, T=−2.0, p=0.04; TRP-, T=−3.3, p=0.002). No effect of ATD was found on the RT measures.
Subjective measures
Data from the POMS questionnaire, which was complete for all 13 participants, showed that no effect of ATD was found on the subscales for depression [F(1,11) F(1,11)=9.8, P<0 .05]. At t0, the participants felt more vigorous (total score of five vigor items is 207; SE=17.6) than at t5 (total score of five vigor items is 224; SE=13.2).
Data of one subject were missing from the physical complaints list (n=12). No effect of ATD on physical complaints was found [F(1,10)=1.8, P=NS]. In the BAL condition, the participants had on average a total score of 3.3 (SE=0.9) at t0 and 4.2 (SE=1.0) at t5. In the TRPcondition, the participants had on average a total score of 2.2 (SE=0.8) at t0 and 3.6 (SE=1.0) at t5.
Discussion
The present study investigated the effect of a transient lowering of 5-HT on performance monitoring and response inhibition related brain activation in 13 healthy male volunteers. In line with previous studies (Asahi et al. 2004; Durston et al. 2002; Garavan et al. 1999 Garavan et al. , 2002 Garavan et al. , 2003 Horn et al. 2003; Kelly et al. 2004; Liddle et al. 2001; Menon et al. 2001; Rubia et al. 2003) , the present study showed that a widespread network of associated brain regions is involved in response inhibition, including areas in the frontal, parietal, and the temporal cortex. ATD successfully decreased plasma TRP (−59%) and the TRP/ ΣLNAA ratio (−77%) but did not affect mood and task performance. ATD decreased the BOLD response in the dmPFC (BA 8) during performance monitoring and did not change the BOLD response during response inhibition.
Performance monitoring
The present study revealed that ATD modulated the BOLD response in the dmPFC during performance monitoring in a Go/NoGo paradigm in healthy volunteers. The dmPFC was associated with cognitive flexibility. Previous studies showed that the dmPFC (BA 8) is involved in switching behavior during a reversal learning task (Cools et al. 2002; Kringelbach and Rolls 2003; Remijnse et al. 2005) and response uncertainty during a decision-making task (Volz et al. 2004 (Volz et al. , 2005 . Moreover, the medial prefrontal cortex is strongly innervated by the 5-HT projections from the rostral raphe nuclei (for review, see Hornung 2003) . In line with these findings, a previous pharmacological neuroimaging 384 (4) 379 (6) n=141 n=110 study (Evers et al. 2005) reported that ATD modulates the BOLD response in the dmPFC after a final reversal error in a probabilistic reversal learning task in healthy volunteers. These data suggest a role for 5-HT in the functioning of the dmPFC during cognitive flexibility tasks.
To examine the effect of ATD on performance monitoring, we calculated the mean reaction time on the correct response after an error (see Table 2 ). It is a well-documented finding that participants slow down after an error (post error slowing, first postulated by Rabbitt 1966). It is noteworthy that, although ATD changed the BOLD response in the dmPFC during performance monitoring, we did not find reaction time changes on a correct trial after negative feedback. The performance measures used in this study might not have been sensitive enough to pick up subtle behavioral changes associated with the changed brain activation. Several previous ATD studies also failed to find behavioral effects accompanying the reported effects of ATD on brain activation (Evers et al. 2005; Horacek et al. 2005; Rubia et al. 2005) .
In contrast with the present study, which showed that ATD decreased the BOLD response in the dmPFC during performance monitoring, our research group (Evers et al. 2005) showed in a previous study that ATD increased the BOLD response in the dmPFC after a last reversal error in a probabilistic reversal-learning task. This opposite effect might be related to the different meaning of the negative feedback in the reversal learning and the Go/NoGo task. In the probabilistic reversal learning task, negative feedback after a last reversal error signaled a response error due to a change of the stimulus-response rule, whereas in the Go/NoGo task, negative feedback signaled a response error due to suboptimal performance. Clearly, this hypothesis needs to be tested by future research. Aside from taskrelated differences, there might be another explanation for the contradictory findings. Because ATD studies showed contradictory findings in the past (for example, Rogers et al. 1999 vs Talbot et al. 2005 , Talbot et al. (2005) hypothesized that personality characteristics play a decisive role in the effect of ATD on performance and brain activation. Support for this hypothesis is provided by behavioral ATD studies that showed that ATD only affects sensitive individuals. For example, ATD lowers mood in individuals with a positive family history of major depression (see review Riedel et al. 2002) and in individuals that are susceptible to lowered mood or aggression (for review, see Young and Leyton 2002) . Moreover, Cools et al. (2005b) showed that ATD modulates the amygdala activation in response to fearful faces as a function of self-reported threat sensitivity, and that ATD impaired motivational guidance of goal-directed behavior on a cued-reinforcement reaction time task as a function of the trait impulsivity (Cools et al. 2005a) . Because in our previous and present study participants were not screened and selected on the basis of personality traits, it is possible that unknown personality differences influenced the results. Clearly, this hypothesis needs to be tested by future research. The present study suggests that individual mood changes do not account for these inconsistencies. Fallgatter et al. (2004) reported that carriers of the short allele variant of a functional length variation in the transcriptional control region of the 5-HT transporter gene, which was associated with an increased risk for depression and anxiety (for review, see Hariri et al. 2006) , showed higher amplitude of the error-related negativity compared to carriers of two long alleles. This indicates that a short allele is associated with an enhanced responsiveness of the anterior cingulate cortex (ACC) during error processing. The present study did not show an effect of low 5-HT on ACC activation, but did show decreased activation in the dmPFC after ATD during performance monitoring. The decreased dmPFC activation did not overlap with the taskrelated ACC activation in the BAL condition during performance monitoring. Differences in the experimental design and the 5-HT manipulation might explain the differential effect of low 5-HT on brain activation in these studies. Future studies directly examining the effects of ATD on the ERN (Error-related negativity) might increase our insight in the effect of low 5-HT in dorsomedial frontal regions during performance monitoring.
Response inhibition
The present study did not show that ATD modulated the BOLD response in the right inferior frontal cortex, as the study by Rubia et al. (2005) reported. This might be due to task-and design-related differences in the Go/NoGo tasks that were used. First, the present study used a more difficult Go/NoGo task. The participant had to respond faster due to a predefined time range and, instead of different symbols, the same symbols were used for Gos and NoGos. Due to these differences participants responded faster (375 ms vs 459 ms) and made more errors (70% vs 98% of the NoGo trials were successful) in the present study as compared with Rubia's study. Second, performance feedback was given during the task used in the present study. Third, in the study of Rubia et al. both females and males were tested, while in our study only males were used. Previous studies showed that females respond differently to ATD than males do. Booij et al. (2002) showed that total and free plasma TRP decreased more in females than in males after ATD. Harmer et al. (2003) showed that tryptophan depletion decreased recognition of fear in female, but not in male, volunteers. At the moment, the extent to which the effect of ATD on the BOLD response during cognitive flexibility tasks differs between males and females remains unclear.
The lack of effect of ATD on performance is in agreement with studies that did not find behavioral effects of ATD on response inhibition Cools et al. 2005a , Le Marquand et al. 1998 Rubia et al. 2005) . These studies used a Go/NoGo task or a stop signal task to measure response inhibition. In contrast, a study by Walderhaug et al. (2002) reported that ATD increased an impulsive response style on a continuous performance task (CPT) in healthy volunteers. An increase in impulsive response style on the CPT indicates that subjects responded more often to correct stimuli and to catch trials. Because impaired response inhibition on a Go/NoGo or a Stop Signal Task and an impulsive response style on a CPT task reflect a different impairment, it is possible that ATD affects these measures differently.
Conclusions
The present study showed that ATD modulated the BOLD response during performance monitoring, while leaving performance unchanged. This is in agreement with other studies that showed that 5-HT is implicated in cognitive flexibility. Because ATD studies have revealed inconsistent effects of ATD on performance and on brain activation, it was hypothesized that the effect of ATD might depend on gender and personality characteristics. Clearly, more research is needed to unravel the effects of low 5-HT on cognitive flexibility.
